Bug Speaks
Bug Speaks (Leucine Rich Bio Pvt Ltd) is a Bangalore-based microbiome diagnostics company offering at-home gut and skin microbiome test kits with personalized dietary, disease-risk, and supplement recommendations powered by proprietary metagenome sequencing, sold direct-to-consumer globally with clinic-partner distribution.
- Company typePrivate
- Founded2014
- HeadquartersBangalore, India
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Bug Speaks does
Bug Speaks (legally Leucine Rich Bio Pvt Ltd) is a Bangalore-based microbiome diagnostics company founded in 2014 that operates South Asia's first clinically validated at-home microbiome test platform. Its core offering is a $370 Gut Microbiome Test that uses metagenome sequencing — rather than 16s rDNA — to classify microbial composition at species and strain level across bacteria, archaea, fungi, viruses, and worms. The platform's analytical layer comprises three proprietary assets: the Rych Index algorithm that aggregates abundance, diversity, and richness into a composite gut-health score; the MicroByte database of curated microbiota–disease associations; and the NutriBite database of curated microbiota–food associations. These power disease susceptibility estimates and a 3-phase personalized nutritional and supplement recommendation delivered with expert consultation. A Skin Microbiome Test was launched in 2026, with Oral and Vaginal tests planned, and the company sells a complementary RychBiome line of probiotic capsules and a skin-microbiome balancing cream.
The business is structured as a direct-to-consumer e-commerce operation on bugspeaks.com with global shipping (10 countries including India, UK, USA, UAE, Singapore, and Brazil), supported by a clinic-partner distribution network (Healing Hands Clinic, Viecell, Plexus/Smart Revive, Micro Health Labs Qatar) and a dedicated Middle East unit in Dubai. Revenue is generated primarily through one-time test-kit purchases ($370 for the gut test, with a 50% retest discount for returning customers), bundled expert consultations, and proprietary supplement sales; COD and EMI options are offered for accessibility. Customer acquisition is driven by content marketing (31 pages of educational blog content, Gut and Skin quizzes), social media, expert video collaborations, the proprietary "World of Microbiome" event, and earned media across major Indian business and health publications. The company holds ISO 9001:2015 and ISO/IEC 17025:2017 certifications plus NABL and NABH accreditations — the only microbiome company in Asia with this combination — and is bootstrapped with no disclosed funding rounds, operating at 11–50 employees.
Bug Speaks firmographics
Firmographics- Name
- Bug Speaks
- Legal name
- Leucine Rich Bio Pvt Ltd
- Website
- https://bugspeaks.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bug Speaks (Leucine Rich Bio Pvt Ltd) is a Bangalore-based microbiome diagnostics company offering at-home gut and skin microbiome test kits with personalized dietary, disease-risk, and supplement recommendations powered by proprietary metagenome sequencing, sold direct-to-consumer globally with clinic-partner distribution.
- Ownership category
- akta.pro rank
Bug Speaks industry classification
Industry- Product category
- Microbiome Testing
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH)
- akta.pro secondary industry
- Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)
Keywords
Where Bug Speaks is headquartered
LocationHeadquarters
- HQ city
- Bangalore
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Bug Speaks business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Microbiome Test Kits: One-time purchase of at-home test kits (Gut Microbiome Test, Skin Microbiome Test) with included consultation. Customers pay upfront for the kit, sample collection, lab analysis, and expert consultation services bundled together. Retest discount of 50% offered for repeat customers.
- Probiotic Supplements (RychBiome): Sale of proprietary probiotic capsules (RychBiome) and other wellness products for gut and skin health. RychBiome Indus Plus, RychBiome Indus, and Skin Microbiome Balancing Cream are sold as complementary products to test results.
- Expert Consultation Services: Bundled expert consultation with test kits providing personalized解读 of microbiome reports and one month of tailored nutritional support. Ongoing consultation services for extended wellness support.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | BugSpeaks Gut Microbiome Test - Comprehensive gut health analysis with expert consultation |
Go-to-market motion4 records
Distribution channels3 records
Marketing channels8 records
Bug Speaks product offering
Product offeringCore offering
BugSpeaks sells at-home microbiome test kits (Gut and Skin) that use metagenome sequencing to characterize microbial composition at species and strain level. Customers self-collect samples, mail them to the lab, and receive a personalized report covering disease susceptibility, a 3-phase nutritional plan, probiotic/prebiotic recommendations, and an expert consultation. The company also sells complementary RychBiome probiotic supplements and a microbiome-balancing skin cream.
Product overview
BugSpeaks is a microbiome testing platform comprising multiple at-home test kits (Gut, Skin, Oral, and Vaginal Microbiome Tests), proprietary databases (MicroByte, NutriBite), and algorithmic outputs (Rych Index) for personalised health recommendations. The core offering is the clinically validated Gut Microbiome Test using metagenome sequencing, supplemented by the Skin Microbiome Test and forthcoming Oral/Vaginal tests. The product portfolio also includes RychBiome supplement products (probiotic capsules, skin cream) and digital assessment tools (Gut/Skin Health Quizzes). All tests provide expert consultation and personalised dietary/probiotic recommendations powered by proprietary analytics.
Differentiator
Problem solved
Functional benefit
Brands
- RychBiome™: Probiotic capsules for gut health - supplement product line
- Rych Index
- MicroByte
- NutriBite
Products and services
- BugSpeaks Gut Microbiome Test At-home gut microbiome test kit that analyzes stool sample composition using metagenome sequencing to identify microbial diversity, abundance, pathogens, and probiotics, providing a personalized 3-phase nutritional plan, disease susceptibility estimates, probiotic/prebiotic recommendations, and an expert consultation with one month of nutritional support. Targeted at health-conscious consumers seeking personalized gut health insights.
- BugSpeaks Skin Microbiome Test At-home skin microbiome test kit that analyzes facial skin microbial composition through swab samples, delivering a personalized skincare assessment with ingredient recommendations, probiotic/prebiotic guidance, and expert consultation. Designed for consumers concerned with skin conditions and microbiome-driven skincare.
- RychBiome Probiotic Capsules Gut health probiotic and prebiotic supplement capsules formulated to support microbiome balance and gut wellness, sold as a complementary product to the BugSpeaks Gut Microbiome Test.
- RychBiome Indus Probiotic supplement formulated to support gut microbiome diversity, developed and sold by BugSpeaks as part of the RychBiome product line.
- RychBiome Indus Plus Advanced probiotic formulation for enhanced gut health support, sold as part of BugSpeaks' RychBiome supplement range.
- RychBiome Skin Microbiome Balancing Cream Topical microbiome-balancing skincare cream formulated to actively nourish and balance living skin bacteria. Marketed as India's first skin microbiome-centric healthcare product and sold as a complement to the BugSpeaks Skin Microbiome Test.
Quantifiable outcome
- 40K+ test samples analyzed
- +3 more outcomes
Companies that use Bug Speaks
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Bug Speaks technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature6 records
Bug Speaks partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Healing Hands CliniccorePartner clinic for integrative gut health services. Healing Hands Clinic offers BugSpeaks microbiome testing as part of comprehensive digestive health and wellness programs. The partnership enables clinical validation and professional recommendation of testing services.
- Viecell (Dr. Ankur Patel)coreStem cell therapy and regenerative medicine clinic partnership. Viecell integrates BugSpeaks microbiome testing with stem cell treatment protocols for holistic wellness programs targeting gut health restoration.
- Plexus Healthcare / Smart ReviveminorRehabilitation and wellness clinic network distributing BugSpeaks testing services to patients seeking personalized gut health solutions.
- Micro Health Labs (Qatar)minorInternational distribution partner launching BugSpeaks in Qatar market, pioneering gut microbiome testing globally in the Middle East region.
- RelianceminorMajor Indian conglomerate ecosystem partner, nature of collaboration not explicitly detailed in available sources.
Scale indicators9 records
Recent moves11 records
Expansion highlights5 records
Bug Speaks competitors and assessment
Company assessmentDirect peers
- ZOE: UK-based personalized nutrition company combining gut microbiome testing with continuous glucose monitoring and blood fat analysis. Targets similar health-conscious consumer segment with a test-plus-coaching model.
- DayTwo: Israel/US gut microbiome testing company using metagenomic sequencing to provide personalized nutrition for glycemic control. Closely aligned with BugSpeaks on sequencing technology and personalized dietary outputs.
- Viome: US-based DTC microbiome testing company offering at-home gut and oral microbiome tests with personalized nutrition recommendations. Directly competes with BugSpeaks in metagenome-based consumer microbiome diagnostics.
- Biohm Health: US gut and mycobiome (fungi-focused) microbiome testing company offering personalized probiotic and dietary recommendations. Directly comparable gut-microbiome-plus-supplement business model.
- Atlas Biomed: UK-based DTC microbiome and DNA testing company offering gut microbiome test kits with personalized health and nutrition recommendations. Similar at-home kit model and disease-risk framing.
Emerging players
- S-Biomedic: Belgium-based skin microbiome company developing live biotherapeutic products and skin microbiome testing. Directly comparable to BugSpeaks' skin microbiome test and skin-balancing cream product line.
- Carbiotix: Sweden-based microbiome health company focused on soluble fiber prebiotics and microbiome testing services for consumer and B2B applications. Comparable sequencing-based microbiome diagnostics but with B2B emphasis.
Broad incumbents
- Redcliffe Labs: India-based diagnostics chain offering a broad menu of at-home tests. A BugSpeaks lab partner that could also evolve into a direct channel competitor given its reach in Indian consumer diagnostics.
Regional players
- MapmyGenome: India-based personal genomics and preventive health company offering DNA-based health and wellness tests. Comparable Indian DTC consumer-genomics model with overlapping wellness and personalized recommendation positioning.
- Strand Life Sciences: India-based genomics and bioinformatics company (and BugSpeaks technology partner). Comparable in genomics capability and Indian market presence, but serves clinical diagnostics and pharma research rather than consumer microbiome testing.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Bug Speaks social profiles
Digital presenceBug Speaks compliance and trust
Trust signalCompliance4 records
Bug Speaks financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bug Speaks leadership team
Management profileNumber of profiles
Bug Speaks funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bug Speaks M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bug Speaks
What does Bug Speaks do?
BugSpeaks sells at-home microbiome test kits (Gut and Skin) that use metagenome sequencing to characterize microbial composition at species and strain level. Customers self-collect samples, mail them to the lab, and receive a personalized report covering disease susceptibility, a 3-phase nutritional plan, probiotic/prebiotic recommendations, and an expert consultation. The company also sells complementary RychBiome probiotic supplements and a microbiome-balancing skin cream.
Is Bug Speaks a public or private company?
Bug Speaks is a private company. It is classified as unknown and is currently operating.
When was Bug Speaks founded?
Bug Speaks was founded in 2014. It employs 11 to 50 people.
Where is Bug Speaks based?
Bug Speaks is headquartered in Bangalore, India, in the Asia region.
How does Bug Speaks make money?
Three revenue lines are on record. Microbiome Test Kits are the primary driver. The others are probiotic Supplements (RychBiome) and expert Consultation Services.
Who are Bug Speaks's main competitors?
Direct peers on record are ZOE, DayTwo, Viome, Biohm Health and Atlas Biomed. Emerging players are S-Biomedic and Carbiotix. Redcliffe Labs is listed as a broad incumbent. Regional players are MapmyGenome and Strand Life Sciences.
Does Bug Speaks have an API?
No public API is recorded for Bug Speaks.
What industry is Bug Speaks in?
Bug Speaks's product category is Microbiome Testing. Its primary akta.pro industry code is HLAAAFAH, Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal), with a secondary code of HLAFAMAD, Microbiology & Infectious Disease Testing Laboratories. Its NAICS code is 325413 and its SIC code is 2835.